G36.9
BillableAcute disseminated demyelination, unspecified
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is G36.9 an HCC code?
Yes. G36.9 maps to Multiple Sclerosis under the CMS-HCC V28 risk adjustment model (and Multiple Sclerosis under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for G36.9
For G36.9 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed G36.9 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
G36.9 is the ICD-10-CM diagnosis code for acute disseminated demyelination, unspecified. This code describes a sudden onset condition where the protective coating (myelin) around nerve fibers in the brain and spinal cord becomes inflamed and damaged, but the specific type or location is not specified. It's a serious neurological condition that can cause weakness, numbness, vision problems, and other neurological symptoms. G36.9 sits in the ICD-10-CM chapter for diseases of the nervous system (g00-g99), within the section covering demyelinating diseases of the central nervous system (g35-g37).
Under the CMS-HCC V28 risk adjustment model, G36.9 maps to Multiple Sclerosis (HCC 198) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, G36.9 mapped to the same category but with a base RAF weight of 0.476 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code only when the demyelinating condition is acute and disseminated (affecting multiple areas) but the specific type cannot be determined; if a more specific demyelinating disease is identified (such as multiple sclerosis, optic neuritis, or transverse myelitis), use the more specific code instead. Because G36.9 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for G36.9 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code only when the demyelinating condition is acute and disseminated (affecting multiple areas) but the specific type cannot be determined; if a more specific demyelinating disease is identified (such as multiple sclerosis, optic neuritis, or transverse myelitis), use the more specific code instead
- •Ensure documentation supports the acute presentation and disseminated nature; query the provider if only a single lesion or chronic demyelination is documented, as those would require different coding
Clinical Significance
Acute disseminated demyelination, unspecified, captures sudden-onset central nervous system demyelination when the specific type has not been determined. While it represents a documentation improvement opportunity, it still identifies a serious neurological condition requiring acute management. These patients need follow-up to determine whether the condition is monophasic or the onset of a chronic demyelinating disease.
Documentation Requirements
- ✓Documentation of acute onset demyelinating condition affecting multiple CNS areas
- ✓Neuroimaging showing disseminated demyelinating lesions
- ✓Evidence that specific demyelinating diseases have been considered but not yet confirmed
- ✓Acute timeline of symptom onset documented
- ✓Treatment plan for the acute episode
- ✓Plan for follow-up diagnostic evaluation to determine specific diagnosis
Commonly Confused Codes
- •G36.0 — Neuromyelitis optica; specific disease requiring antibody testing
- •G36.8 — Other specified acute disseminated demyelination; use when a specific type is identified
- •G35 — Multiple sclerosis; chronic disease, not acute disseminated
- •G37.9 — Demyelinating disease of CNS, unspecified; broader category including chronic conditions
- •G04.81 — Other encephalitis and encephalomyelitis; inflammatory but may not be demyelinating